World class expertise in the early clinical development of new cancer therapies, built on a world leading pathway from clinic/theatre to bench and back again, and driven by strong national and international collaborations. The Edinburgh ECMC combines the strengths of discovery and translational science at the CRUK Edinburgh Centre, with robust clinical delivery at the Edinburgh Cancer Centre, across broad disease areas and diverse treatment modalities. Focus areas for Edinburgh include immunotherapies, data and molecular targeting, and disease area leadership in breast, ovarian, brain, colorectal and renal cancers and Phase I populations.
Our patient population
The Edinburgh Cancer Centre covers the South East Scotland population of 1.5 million through central and peripheral clinics, as well as quaternary referral from elsewhere, treating all solid and haematological adult and TYA cancers. Each year, around 5000 patients start a course of systemic cancer therapy at the Edinburgh Centre, with another 2500 at our peripheral units. Last year (2019-2020), just over 1000 patients were recruited onto clinical trials.
Organisations affiliated with the Edinburgh ECMC:
University of Edinburgh, NHS Lothian, NHS Fife, NHS Borders, NHS Dumfries & Galloway
The Edinburgh ECMC is located in the city of Edinburgh, South East Scotland, within walking distance of the city centre and within 2 miles of the two main train stations: Edinburgh Waverley and Edinburgh Haymarket. As the capital city of Scotland, Edinburgh is a major transport hub for trains, coaches and planes within the UK. Edinburgh International Airport is 6.5 miles by taxi and has excellent national and international connections.
Contact the Centre Manager: